MAK Capital Fund reported a 5.8% stake in Protalix BioTherapeutics PLX · 4,649,599 sh · passive holder

Trade details

Type: 5% stake report
Report: 13G passive
Stake: 5.8%
Last report: First report
Shares held: 4,649,599 sh
Class: Common Stock, $0.001 par value per share
Stock: Protalix BioTherapeutics PLX
Holder: MAK Capital Fund
Event date: 26/02/26
Filed: 26/03/04

First 5%+ report · 5.8% stake

Protalix BioTherapeutics trades, last 26 weeks

What else happened in Protalix BioTherapeutics around then

Filed or reported within 30 days of the trade day · 01/27~03/28

MAK Capital Fund's other 5% stake reports

MAK Capital Fund
5% stakeComstock
5% stake
Comstock
LODE
6.7% stake
5,065,656 sh
6.7% stake
Filed 09/16
MAK Capital Fund
5% stakeStandard Biotools
5% stake
Standard Biotools
LAB
6.7% stake
26,172,626 sh
6.7% stake
Filed 05/15
MAK Capital Fund
5% stakeAutolus Therapeutics
5% stake
Autolus Therapeutics
AUTL
12.6% stake
33,621,487 sh
12.6% stake
Filed 05/15
MAK Capital Fund
5% stakeEvotec
5% stake
Evotec
EVO
7.1% stake
12,681,898 sh
7.1% stake
Filed 05/01
MAK Capital Fund
5% stakeEvotec
5% stake
Evotec
EVO
7% stake
12,503,512 sh
7% stake
Filed 04/06